Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have chronic kidney disease caused by high blood pressure, across a range of severity levels, who do not have diabetes and do not smoke
- People who have high blood pressure (diagnosed according to 2023 international guidelines) but do not yet have kidney damage, and who do not have diabetes and do not smoke
- Healthy volunteers who are willing to participate as a comparison group
Who may not be able to join:
- People whose kidney disease is caused by something other than high blood pressure
- People who have hormonal (endocrine), autoimmune, or inflammatory conditions that could affect how the kidneys work
- People who smoke
- People who have diabetes
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ines Drenjančević, MD, PhD, Faculty of Medicine Josip Juraj Strossmayer University of Osijek
Phone: +385912241406
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Microvascular reactivity; Endothelial glycocalyx
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.